Candidiasis of other urogenital sites
ICD-10 B38.2 is a billable code used to indicate a diagnosis of candidiasis of other urogenital sites.
Candidiasis of other urogenital sites refers to fungal infections caused by Candida species, primarily Candida albicans, affecting areas of the urogenital tract that are not classified under more specific codes. This condition can manifest in various forms, including vulvovaginal candidiasis, urethritis, and infections of the bladder or other urogenital structures. Symptoms may include itching, burning, abnormal discharge, and discomfort during urination or sexual intercourse. The risk of developing candidiasis increases in immunocompromised patients, such as those with HIV/AIDS, diabetes, or those undergoing immunosuppressive therapy. Diagnosis typically involves clinical evaluation and laboratory tests, including culture and sensitivity testing. Treatment often includes antifungal medications such as fluconazole or topical agents like clotrimazole. It is crucial for healthcare providers to consider the patient's overall health status and any underlying conditions when diagnosing and treating candidiasis of other urogenital sites.
Detailed patient history, including immunocompromised status and previous infections.
Patients presenting with recurrent candidiasis or those with underlying conditions such as diabetes or HIV.
Consideration of antifungal resistance and the need for culture and sensitivity testing.
Clear documentation of urinary symptoms and any relevant imaging or laboratory results.
Patients with urinary tract symptoms and a history of candidiasis.
Differentiating between candidiasis and other urogenital infections.
When a culture is performed to confirm candidiasis diagnosis.
Document the reason for the culture and the site from which it was obtained.
Infectious disease specialists may require additional lab results.
Common symptoms include itching, burning during urination, abnormal discharge, and discomfort during sexual intercourse.
Diagnosis is typically made through clinical evaluation and may include laboratory tests such as cultures to identify the Candida species.
Treatment options include antifungal medications such as fluconazole, clotrimazole, and other topical agents, depending on the severity and site of infection.
